$TLCR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Talecris Biotherapeutics Holdings Corp..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Talecris Biotherapeutics Holdings Corp.. Get notifications about new insider transactions in Talecris Biotherapeutics Holdings Corp. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Option Exercise | D | 1.39 | 843,520 | 1,172,493 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Option Exercise | D | 21.25 | 2,016,000 | 42,840,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Option Exercise | D | 1.39 | 1,265,280 | 1,758,739 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Option Exercise | D | 19.00 | 90,070 | 1,711,330 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Sell | D | 0.00 | 970,136 | 0 | 0 | 970.1 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Sell | D | 0.00 | 161,850 | 0 | 0 | 161.9 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | D | 1.39 | 249,040 | 346,166 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | D | 19.00 | 18,286 | 347,434 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | D | 0.00 | 42,796 | 0 | 0 | 42.8 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CHARPIE RICHARD A | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CHARPIE RICHARD A | Director | Sell | D | 0.00 | 3,019 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Perkins John R II | Sr.VP & GM, Portfol ... | Option Exercise | D | 11.00 | 42,176 | 463,936 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Perkins John R II | Sr.VP & GM, Portfol ... | Option Exercise | D | 19.00 | 11,755 | 223,345 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Perkins John R II | Sr.VP & GM, Portfol ... | Sell | D | 0.00 | 26,820 | 0 | 0 | 26.8 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Nogales Bruce | Sr. VP & GM, Plasma ... | Option Exercise | D | 19.00 | 11,755 | 223,345 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Nogales Bruce | Sr. VP & GM, Plasma ... | Sell | D | 0.00 | 8,225 | 0 | 0 | 8.2 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Option Exercise | D | 11.00 | 40,000 | 440,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Option Exercise | D | 11.00 | 20,000 | 220,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Option Exercise | D | 19.00 | 11,755 | 223,345 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Sell | D | 0.00 | 19,317 | 0 | 0 | 19.3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Option Exercise | D | 19.00 | 5,224 | 99,256 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Sell | D | 0.00 | 3,655 | 0 | 0 | 3.7 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Option Exercise | D | 11.00 | 108,000 | 1,188,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Option Exercise | D | 19.00 | 7,836 | 148,884 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Sell | D | 0.00 | 5,484 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Option Exercise | D | 11.00 | 420,000 | 4,620,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Option Exercise | D | 11.00 | 256,000 | 2,816,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Option Exercise | D | 19.00 | 26,123 | 496,337 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Sell | D | 0.00 | 23,072 | 0 | 0 | 23.1 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | D | 1.39 | 279,416 | 388,388 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | D | 19.00 | 18,286 | 347,434 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | D | 0.00 | 63,779 | 0 | 0 | 63.8 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Option Exercise | D | 11.00 | 26,360 | 289,960 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Option Exercise | D | 11.00 | 105,440 | 1,159,840 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Option Exercise | D | 1.39 | 421,760 | 586,246 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Option Exercise | D | 19.00 | 35,266 | 670,054 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Sell | D | 0.00 | 89,331 | 0 | 0 | 89.3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MITCHELL DEAN J | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MITCHELL DEAN J | Director | Option Exercise | D | 20.99 | 9,367 | 196,613 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MITCHELL DEAN J | Director | Sell | D | 0.00 | 3,019 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Waeger Ruedi E | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Waeger Ruedi E | Director | Option Exercise | D | 16.63 | 7,848 | 130,512 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Waeger Ruedi E | Director | Option Exercise | D | 9.88 | 12,616 | 124,646 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Waeger Ruedi E | Director | Option Exercise | D | 1.39 | 210,880 | 293,123 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Waeger Ruedi E | Director | Sell | D | 0.00 | 63,587 | 0 | 0 | 63.6 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MAYER STEVEN F | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MAYER STEVEN F | Director | Sell | D | 0.00 | 3,019 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MARTIN KENNETH J | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MARTIN KENNETH J | Director | Option Exercise | D | 16.63 | 7,848 | 130,512 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MARTIN KENNETH J | Director | Option Exercise | D | 9.88 | 12,616 | 124,646 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MARTIN KENNETH J | Director | Option Exercise | D | 11.00 | 8,576 | 94,336 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | MARTIN KENNETH J | Director | Sell | D | 0.00 | 12,715 | 0 | 0 | 12.7 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | D | 11.00 | 8,000 | 88,000 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | D | 1.39 | 28,464 | 39,565 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | D | 19.00 | 5,224 | 99,256 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Sell | D | 0.00 | 3,655 | 0 | 0 | 3.7 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Lenehan James T | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Lenehan James T | Director | Option Exercise | D | 16.63 | 7,848 | 130,512 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Lenehan James T | Director | Option Exercise | D | 9.88 | 12,616 | 124,646 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Lenehan James T | Director | Option Exercise | D | 1.39 | 527,200 | 732,808 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Lenehan James T | Director | Sell | D | 0.00 | 139,891 | 0 | 0 | 139.9 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | INGERSOLL W BRETT | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | INGERSOLL W BRETT | Director | Sell | D | 0.00 | 3,019 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CLARK PAUL N | Director | Option Exercise | D | 19.87 | 6,256 | 124,307 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CLARK PAUL N | Director | Option Exercise | D | 16.63 | 7,848 | 130,512 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CLARK PAUL N | Director | Option Exercise | D | 9.88 | 12,616 | 124,646 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CLARK PAUL N | Director | Option Exercise | D | 11.00 | 8,576 | 94,336 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | CLARK PAUL N | Director | Sell | D | 0.00 | 12,715 | 0 | 0 | 12.7 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Option Exercise | D | 11.00 | 96,360 | 1,059,960 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Option Exercise | D | 19.00 | 11,755 | 223,345 | 0 | |
Jun 03 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Sell | D | 0.00 | 8,810 | 0 | 0 | 8.8 K to 0 (-100.00 %) |
Jun 03 2011 | TLCR | Talecris Biotherap ... | AMP-99 MANAGEMENT CO LLC | 10% Owner | Sell | U | 0.00 | 15,707,155 | 0 | 0 | 15.7 M to 0 (-100.00 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Payment of Exercise | F | 26.94 | 4,180 | 112,609 | 42,796 | 47 K to 42.8 K (-8.90 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Grant | A | 0.00 | 6,778 | 0 | 46,976 | 40.2 K to 47 K (+16.86 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Perkins John R II | Sr.VP & GM, Portfol ... | Payment of Exercise | F | 26.94 | 2,839 | 76,483 | 26,820 | 29.7 K to 26.8 K (-9.57 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Perkins John R II | Sr.VP & GM, Portfol ... | Grant | A | 0.00 | 6,778 | 0 | 29,659 | 22.9 K to 29.7 K (+29.62 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Nogales Bruce | Sr. VP & GM, Plasma ... | Payment of Exercise | F | 26.94 | 2,053 | 55,308 | 8,225 | 10.3 K to 8.2 K (-19.97 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Nogales Bruce | Sr. VP & GM, Plasma ... | Grant | A | 0.00 | 4,357 | 0 | 10,278 | 5.9 K to 10.3 K (+73.59 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Payment of Exercise | F | 26.94 | 2,053 | 55,308 | 19,317 | 21.4 K to 19.3 K (-9.61 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Menichella Daniel L | Sr. VP, Business De ... | Grant | A | 0.00 | 4,357 | 0 | 21,370 | 17 K to 21.4 K (+25.61 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Payment of Exercise | F | 26.94 | 4,180 | 112,609 | 63,779 | 68 K to 63.8 K (-6.15 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Grant | A | 0.00 | 6,778 | 0 | 67,959 | 61.2 K to 68 K (+11.08 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Payment of Exercise | F | 26.94 | 912 | 24,569 | 3,655 | 4.6 K to 3.7 K (-19.97 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Grant | A | 0.00 | 1,936 | 0 | 4,567 | 2.6 K to 4.6 K (+73.58 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Payment of Exercise | F | 26.94 | 1,368 | 36,854 | 5,484 | 6.9 K to 5.5 K (-19.96 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Grant | A | 0.00 | 2,905 | 0 | 6,852 | 3.9 K to 6.9 K (+73.60 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Payment of Exercise | F | 26.94 | 3,621 | 97,550 | 23,072 | 26.7 K to 23.1 K (-13.57 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | GAITHER JOHN F JR | Exec.VP,General Cou ... | Grant | A | 0.00 | 6,778 | 0 | 26,693 | 19.9 K to 26.7 K (+34.03 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Payment of Exercise | F | 26.94 | 4,592 | 123,708 | 89,331 | 93.9 K to 89.3 K (-4.89 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Hanson John M | Executive VP & CFO | Grant | A | 0.00 | 8,232 | 0 | 93,923 | 85.7 K to 93.9 K (+9.61 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Payment of Exercise | F | 26.94 | 912 | 24,569 | 3,655 | 4.6 K to 3.7 K (-19.97 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Grant | A | 0.00 | 1,936 | 0 | 4,567 | 2.6 K to 4.6 K (+73.58 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Payment of Exercise | F | 26.94 | 1,468 | 39,548 | 8,810 | 10.3 K to 8.8 K (-14.28 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Grant | A | 0.00 | 4,357 | 0 | 10,278 | 5.9 K to 10.3 K (+73.59 %) |
Apr 04 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Payment of Exercise | F | 26.80 | 82,067 | 2,199,396 | 149,899 | 232 K to 149.9 K (-35.38 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Payment of Exercise | F | 26.94 | 21,442 | 577,647 | 161,850 | 183.3 K to 161.9 K (-11.70 %) |
Apr 05 2011 | TLCR | Talecris Biotherap ... | Stern Lawrence D | Chairman & CEO | Grant | A | 0.00 | 33,393 | 0 | 183,292 | 149.9 K to 183.3 K (+22.28 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | M | 1.39 | 20,000 | 27,800 | 249,040 | |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | S | 24.37 | 25,000 | 609,210 | 40,198 | 65.2 K to 40.2 K (-38.34 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Buy | M | 1.39 | 20,000 | 27,800 | 65,198 | 45.2 K to 65.2 K (+44.25 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | M | 1.39 | 54,697 | 76,029 | 279,416 | |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | S | 24.36 | 54,697 | 1,332,320 | 61,181 | 115.9 K to 61.2 K (-47.20 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Buy | M | 1.39 | 54,697 | 76,029 | 115,878 | 61.2 K to 115.9 K (+89.40 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Option Exercise | M | 11.00 | 15,000 | 165,000 | 96,360 | |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Sell | S | 24.38 | 15,000 | 365,715 | 5,921 | 20.9 K to 5.9 K (-71.70 %) |
Feb 02 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Buy | M | 11.00 | 15,000 | 165,000 | 20,921 | 5.9 K to 20.9 K (+253.34 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | M | 1.39 | 54,697 | 76,029 | 334,113 | |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | S | 23.08 | 54,697 | 1,262,374 | 61,181 | 115.9 K to 61.2 K (-47.20 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Buy | M | 1.39 | 54,697 | 76,029 | 115,878 | 61.2 K to 115.9 K (+89.40 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | M | 1.39 | 20,000 | 27,800 | 269,040 | |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | S | 23.06 | 25,000 | 576,595 | 45,198 | 70.2 K to 45.2 K (-35.61 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Buy | M | 1.39 | 20,000 | 27,800 | 70,198 | 50.2 K to 70.2 K (+39.84 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Option Exercise | M | 11.00 | 45,000 | 495,000 | 111,360 | |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Sell | S | 23.08 | 45,000 | 1,038,582 | 5,921 | 50.9 K to 5.9 K (-88.37 %) |
Jan 04 2011 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Buy | M | 11.00 | 45,000 | 495,000 | 50,921 | 5.9 K to 50.9 K (+760.01 %) |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | M | 1.39 | 20,000 | 27,800 | 289,040 | |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | S | 21.50 | 25,000 | 537,500 | 50,198 | 75.2 K to 50.2 K (-33.25 %) |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Buy | M | 1.39 | 20,000 | 27,800 | 75,198 | 55.2 K to 75.2 K (+36.23 %) |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | M | 1.39 | 27,408 | 38,097 | 28,464 | |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Sell | S | 21.50 | 27,408 | 589,272 | 2,631 | 30 K to 2.6 K (-91.24 %) |
Dec 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Buy | M | 1.39 | 27,408 | 38,097 | 30,039 | 2.6 K to 30 K (+1,041.73 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | M | 1.39 | 46,130 | 64,121 | 388,810 | |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | S | 24.37 | 46,130 | 1,124,225 | 61,181 | 107.3 K to 61.2 K (-42.99 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Buy | M | 1.39 | 46,130 | 64,121 | 107,311 | 61.2 K to 107.3 K (+75.40 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | M | 1.39 | 20,000 | 27,800 | 309,040 | |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | S | 24.37 | 25,000 | 609,258 | 55,198 | 80.2 K to 55.2 K (-31.17 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Buy | M | 1.39 | 20,000 | 27,800 | 80,198 | 60.2 K to 80.2 K (+33.22 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | M | 1.39 | 12,656 | 17,592 | 55,872 | |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Sell | S | 24.37 | 12,656 | 308,446 | 2,631 | 15.3 K to 2.6 K (-82.79 %) |
Nov 02 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Buy | M | 1.39 | 12,656 | 17,592 | 15,287 | 2.6 K to 15.3 K (+481.03 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Option Exercise | M | 1.39 | 46,130 | 64,121 | 434,940 | |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | S | 22.84 | 46,130 | 1,053,415 | 61,181 | 107.3 K to 61.2 K (-42.99 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Buy | M | 1.39 | 46,130 | 64,121 | 107,311 | 61.2 K to 107.3 K (+75.40 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Option Exercise | M | 1.39 | 36,912 | 51,308 | 68,528 | |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Sell | S | 22.81 | 36,912 | 841,948 | 2,631 | 39.5 K to 2.6 K (-93.35 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Engle James R | Sr. VP, Information ... | Buy | M | 1.39 | 36,912 | 51,308 | 39,543 | 2.6 K to 39.5 K (+1,402.96 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Option Exercise | M | 11.00 | 30,000 | 330,000 | 156,360 | |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Sell | S | 22.82 | 30,000 | 684,516 | 5,921 | 35.9 K to 5.9 K (-83.52 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Abelson Joel E | Sr VP & GM, Int'l B ... | Buy | M | 11.00 | 30,000 | 330,000 | 35,921 | 5.9 K to 35.9 K (+506.67 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Option Exercise | M | 1.39 | 20,000 | 27,800 | 329,040 | |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Sell | S | 22.81 | 25,000 | 570,150 | 60,198 | 85.2 K to 60.2 K (-29.34 %) |
Oct 04 2010 | TLCR | Talecris Biotherap ... | Petteway Stephen R Jr | Executive VP, R&D | Buy | M | 1.39 | 20,000 | 27,800 | 85,198 | 65.2 K to 85.2 K (+30.68 %) |
Sep 22 2010 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Option Exercise | M | 11.00 | 108,000 | 1,188,000 | 108,000 | |
Sep 22 2010 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Sell | S | 23.06 | 108,000 | 2,490,534 | 3,947 | 111.9 K to 3.9 K (-96.47 %) |
Sep 22 2010 | TLCR | Talecris Biotherap ... | Heerdt Kari D | Sr. VP, Human Resou ... | Buy | M | 11.00 | 108,000 | 1,188,000 | 111,947 | 3.9 K to 111.9 K (+2,736.26 %) |
Sep 07 2010 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Option Exercise | M | 11.00 | 8,000 | 88,000 | 0 | |
Sep 07 2010 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Option Exercise | M | 1.39 | 105,440 | 146,562 | 0 | |
Sep 07 2010 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Buy | M | 11.00 | 8,000 | 88,000 | 134,560 | 126.6 K to 134.6 K (+6.32 %) |
Sep 07 2010 | TLCR | Talecris Biotherap ... | LYNCH THOMAS J | Sr. VP, Corp. Compl ... | Buy | M | 1.39 | 105,440 | 146,562 | 126,560 | 21.1 K to 126.6 K (+499.24 %) |
Sep 16 2010 | TLCR | Talecris Biotherap ... | Kuhn Mary J | Executive VP, Opera ... | Sell | S | 23.01 | 33,000 | 759,386 | 61,181 | 94.2 K to 61.2 K (-35.04 %) |